INDRAMEDCO Q1 FY26 Earnings Results

Indraprastha Medical Corporation Ltd, incorporated in 1988 as a joint venture between Apollo Hospitals Enterprise Ltd (AHEL) and the Delhi Government, is a super speciality tertiary care hospital in New Delhi and operates 52 speciality departments. Below are its  Q1 FY26 Earnings Results.

Q1 FY26 Earnings Results

• Revenue: ₹1,056 crore, down 3.3% year-on-year (YoY) from ₹1,092 crore in Q1 FY25.
• Total Expenses: ₹1,214 crore, down 3.8% YoY from ₹1,262 crore.
• Consolidated Net Profit (PAT): ₹11 crore, down 93.21% from ₹162 crore in the same quarter last year.
• Earnings Per Share (EPS): ₹3.75, down 89.46% from ₹35.59 YoY.

Operational & Strategic Update

• Revenue Decline: Revenue decreased due to lower patient volumes and possible external disruptions impacting elective and specialty procedures.
• Expense Management: Expenses also declined, but fixed costs and operational overheads limited proportional margin gains.
• Significant Profit Drop: Net profit and EPS plunged sharply, reflecting compressed margins, higher tax impact, and possible absence of extraordinary income compared to the prior year.
• Strategic Focus: The hospital continues to focus on clinical excellence, operational efficiency, and expansion of speciality departments to maintain leadership in tertiary care.

Corporate Developments in Q1 FY26 Earnings

Q1 FY26 results highlight a challenging quarter for Indraprastha Medical Corporation Ltd, marked by significant profit contraction despite cost controls. Recovery efforts are likely focused on process optimization and rejuvenating patient inflows.

Looking Ahead

Indraprastha Medical Corporation Ltd plans to leverage its position as a leading super speciality hospital by deepening its clinical offerings, investing in technology, and enhancing patient care models to restore growth and profitability through FY26 and beyond.

Explore the company’s past earnings and latest concall transcripts, click here to visit the AlphaStreet India News Channel.